Phase 4 MDD Clinical Trials
7 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–7 of 7 trials
Recruiting
Phase 4
The Role of mGluR5 in CBT-I
Major Depressive Disorder (MDD)
Stony Brook University42 enrolled1 locationNCT07076342
Recruiting
Phase 4
PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.
Major Depressive Disorder (MDD)
Stony Brook University14 enrolled1 locationNCT07095205
Recruiting
Phase 4
Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder
Premenstrual Dysphoric Disorder (PMDD)
Johns Hopkins University288 enrolled2 locationsNCT06704594
Recruiting
Phase 4
Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People
Major Depressive Disorder (MDD)
Medical University of Vienna120 enrolled1 locationNCT06675851
Completed
Phase 4
The effect of selective serotonin reuptake inhibitors (SSRIs) on the circadian light response
Major Depressive Disorder (MDD)
Monash University20 enrolled1 locationACTRN12614000807651
Withdrawn
Phase 4
Prevention of Lowered Mood in Major Depressive Disorder with Quetiapine extended release after remission has been induced by electroconvulsive therapy (ECT)
Major Depressive Disorder (MDD)
St Vincent's Hospital40 enrolled1 locationACTRN12610000937011
Recruiting
Phase 4
International Study to Predict Optimized Treatment - in Depression
Major Depressive Disorder (MDD)
Brain Resource2,688 enrolled7 locationsACTRN12608000476336